Biblio
Export 1845 results:
Author [ Title
Filters: First Letter Of Last Name is M [Clear All Filters]
“18F-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 57, no. 3, pp. 711-716, 2017.
, “18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1691-1702, 2018.
, “18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.”, Brain, vol. 134, no. Pt 4, pp. 1089-100, 2011.
, “18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.”, Brain, vol. 134, no. Pt 4, pp. 1089-100, 2011.
, “18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.”, Brain, vol. 134, no. Pt 4, pp. 1089-100, 2011.
, “An 18-mer Peptide Derived from Prosaposin Ameliorates the Effects of Aβ1-42 Neurotoxicity on Hippocampal Neurogenesis and Memory Deficit in Mice.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1173-92, 2016.
, “A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1459-1468, 2017.
, “ABC Transporters Are Key Players in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 2, pp. 463-485, 2018.
, “ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1219-1233, 2016.
, “Aberrant Co-localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-β Peptides: Protective Effect of Human Serum Albumin.”, J Alzheimers Dis, vol. 55, no. 1, pp. 171-182, 2017.
, “Abnormal Functional Brain Networks in Mild Cognitive Impairment and Alzheimer's Disease: A Minimum Spanning Tree Analysis.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1093-1107, 2018.
, “Accelerometer-Measured, Habitual Physical Activity and Circulating Brain-Derived Neurotrophic Factor: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 85, no. 2, pp. 805-814, 2021.
, “Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 241-260, 2023.
, “Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 241-260, 2023.
, “Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 241-260, 2023.
, “Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 241-260, 2023.
, “Accuracy of Inferred APOE Genotypes for a Range of Genotyping Arrays and Imputation Reference Panels.”, J Alzheimers Dis, vol. 64, no. 1, pp. 49-54, 2018.
, “Accuracy of Inferred APOE Genotypes for a Range of Genotyping Arrays and Imputation Reference Panels.”, J Alzheimers Dis, vol. 64, no. 1, pp. 49-54, 2018.
, “Accuracy of Inferred APOE Genotypes for a Range of Genotyping Arrays and Imputation Reference Panels.”, J Alzheimers Dis, vol. 64, no. 1, pp. 49-54, 2018.
, “Accuracy of Inferred APOE Genotypes for a Range of Genotyping Arrays and Imputation Reference Panels.”, J Alzheimers Dis, vol. 64, no. 1, pp. 49-54, 2018.
, “Accuracy of Inferred APOE Genotypes for a Range of Genotyping Arrays and Imputation Reference Panels.”, J Alzheimers Dis, vol. 64, no. 1, pp. 49-54, 2018.
, “Activation of Macrophages and Microglia by Interferon-γ and Lipopolysaccharide Increases Methylglyoxal Production: A New Mechanism in the Development of Vascular Complications and Cognitive Decline in Type 2 Diabetes Mellitus?”, J Alzheimers Dis, vol. 59, no. 2, pp. 467-479, 2017.
, “Activation of Macrophages and Microglia by Interferon-γ and Lipopolysaccharide Increases Methylglyoxal Production: A New Mechanism in the Development of Vascular Complications and Cognitive Decline in Type 2 Diabetes Mellitus?”, J Alzheimers Dis, vol. 59, no. 2, pp. 467-479, 2017.
, “An Active Lifestyle Is Associated with Better Cognitive Function Over Time in APOE ɛ4 Non-Carriers.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1257-1268, 2020.
, “Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1043-50, 2016.
,